Hologic and Inpeco Announce Co-Marketing Partnership to Advance Molecular Laboratory Automation
20.10.2026 14:00:00 CEST | Business Wire | Press Release
Hologic, Inc., a global leader in women’s health and diagnostics, and Inpeco S.A., the global leader in Total Laboratory Automation, today announced they have signed a co-marketing partnership for Inpeco’s automation solution FlexLab™ X and Hologic’s Panther® System in Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020837126/en/
Hologic and Inpeco S.A. announce a co-marketing partnership for Inpeco's automation solution FlexLab™ X and Hologic’s Panther® System in Europe.
Inpeco’s recently launched FlexLab X system enables laboratories to connect multiple Panther Systems. By combining Hologic’s fully-automated molecular diagnostics platform with FlexLab X‘s open automation capabilities, laboratories can achieve high-throughput workflows with the potential to increase sample volumes1 and enhance end-to-end sample traceability2, supporting reliable test results for optimal patient outcomes.3 The Panther System will integrate seamlessly into advanced, fully tracked automation environments, helping high‑throughput molecular laboratories work more efficiently and enhance productivity.1,3,4
“Through our co-marketing partnership with Inpeco, we are helping molecular laboratories take the next step in automation by connecting Hologic’s proven Panther System with Inpeco’s advanced automation technology,” said Frédérique Gallis, Vice President, International Sales and Marketing at Hologic. “Together, we can help customers streamline workflows, increase throughput and enhance pre- and post-analytical sample traceability. This partnership reflects our commitment to delivering scalable solutions that support laboratories as they manage growing testing demands and prepare for the future of molecular diagnostics in an increasingly competitive environment.”
“At Inpeco, we see automation as a key driver of the future of laboratories, through fully automated, touchless and traceable diagnostic processes that begin outside the lab and extend inside,” said Riccardo Triunfo, CEO of Inpeco. “As molecular testing expands, laboratories require solutions that can manage increasing complexity while maintaining performance and reliability. With over 30 years of experience in laboratory automation, we are proud to bring our expertise to this important field. Our partnership with Hologic reflects our common dedication to innovation and our shared goal: helping laboratories embrace the future of molecular diagnostics with high performance and reliability.”
More information about Hologic’s Panther Scalable Solutions can be found here.
More information about Inpeco’s FlexLab X systems can be found here.
About Hologic
Hologic, Inc. is a global leader in women’s health dedicated to developing innovative medical technologies that effectively detect, diagnose and treat health conditions and raise the standard of care around the world. To learn more, visit www.hologic.com and connect with us on LinkedIn, Facebook, X, Instagram and YouTube.
About Inpeco
Inpeco is the global leader in Total Laboratory Automation. The company’s game-changing solutions combine open connectivity with full sample traceability to support secure test results and increase productivity in clinical laboratories around the world. To date, more than 2800 Inpeco systems have been shipped to 78 countries. Inpeco also provides automation for anatomical pathology labs and is developing solutions for blood banks and life sciences applications. The Group is headquartered in Novazzano, Switzerland, and operates a development and manufacturing facility in Italy, as well as sales offices in Europe, the United States, and China.
Forward-Looking Statements
This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.
Hologic, The Science of Sure and Panther are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.
FlexLab is a trademark of Inpeco SA.
References
- Inpeco. Why Lab Automation. https://www.inpeco.com/why-lab-automation/ Last accessed 15 Jul 26.
- Inpeco. FlexLab™ X. https://www.inpeco.com/our-automation-solutions/lab-automation-system/flexlab-x/ Last accessed 15 Jul 26.
- Kim K, Lee SG, Kim TH, et al. Economic Evaluation of Total Laboratory Automation in the Clinical Laboratory of a Tertiary Care Hospital. Ann Lab Med, 2022 Jan 1;42(1):89-95.
- Chih-Wei Tseng, Ying-Chun Li, Herng-Sheng Lee, et al. Laboratory testing consolidation and total laboratory automation improves service efficiency and effectiveness: a study of a medical centre in Taiwan. Laboratory Medicine, November 2024:55 (6):677–685.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261020837126/en/
Contacts
Hologic Media Contact:
Bridget Perry
Senior Director, Corporate Communications
(+1) 508.263.8654
bridget.perry@hologic.com
Inpeco Media Contact:
Markus J. Gross
Head Global Marketing
Markus.Gross@inpeco.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IntouchCX Recognized for Operations led AI and End to End CX Transformation by HFS Research6.11.2026 15:00:00 CET | Press Release
IntouchCX a global leader in AI-powered customer experience (CX) management, trust and safety, digital engagement, and back-office operations, has been positioned in the Horizon 2 end-to-end experience transformation, in the HFS Horizons Customer Experience Services 2026 report for its operations led approach to AI adoption and its model connecting advisory with delivery, from strategy through frontline executions. HFS Research evaluates customer experience service providers based on their capabilities, innovation, and potential to deliver value. The 2026 report examines how providers are helping businesses adopt AI, improve customer experiences and strengthen operations. “AI transformation delivers the greatest value when strategy, technology, and operations work together,” said Brent Stevenson, Chief Experience Officer at IntouchCX. “Our approach and expertise goes beyond technology. We identify business challenges and build the right solutions by connecting the dots between data, wo
The Estée Lauder Companies Unveils Mastering Skin Longevity, a Breakthrough Scientific Innovation Platform Advancing the Next Era of Skin Science6.11.2026 15:00:00 CET | Press Release
At the China International Import Expo (CIIE), The Estée Lauder Companies Inc. (NYSE: EL) today unveiled Mastering Skin Longevity, a breakthrough scientific innovation platform designed to advance the next era of skin science and transformative product innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261106776704/en/ The Estée Lauder Companies' Skin Longevity Clock serves as the visual representation for the Mastering Skin Longevity scientific innovation platform. Moving beyond the study of individual Hallmarks of Aging, the platform focuses further upstream on the Master Regulators of Skin Longevity. These interconnected biological pathways and proteins influence multiple hallmarks at once. By deepening understanding of these systems and how they help support skin’s ability to repair, adapt and regenerate, Mastering Skin Longevity will guide the Company’s discovery across ingredients, technologies, formulations an
Experian Named a Leader in 2026 IDC MarketScape for Worldwide Decision Intelligence Platforms6.11.2026 15:00:00 CET | Press Release
Experian today announced it has been named a Leader in the IDC MarketScape: Worldwide Decision Intelligence Platforms 2026 Vendor Assessment (Doc #US54118426, September 2026), which evaluates providers helping organizations design, engineer and orchestrate increasingly complex decisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261106302874/en/ IDC MarketScape positions Experian as a Leader in its 2026 vendor assessment of worldwide decision intelligence platform providers. “As organizations embed AI into more consequential decisions, the combination of trusted data, advanced analytics and strong governance becomes increasingly important,” said Keith Little, President of Experian Software Solutions. “Experian brings those capabilities together with decisioning, fraud and identity to help organizations make better decisions with greater speed and confidence.” The Experian Ascend Platform provides a unified analytics and
Midas Atlantic Partners, i partnerskap med The Najafi Companies, har ingått ett putoptionsavtal med Sylvamo avseende ett potentiellt förvärv av Sylvamos europeiska verksamhet6.11.2026 12:05:00 CET | Pressmeddelande
Midas Atlantic Partners (”Midas Atlantic”), i partnerskap med The Najafi Companies, har ingått ett putoptionsavtal med Sylvamo Corporation (”Sylvamo”) avseende ett potentiellt förvärv av Sylvamos europeiska verksamhet (”Verksamheten”). Transaktionen omfattar Sylvamos bruk för obestruket träfritt papper i Saillat och Nymölla samt bolagets skogsverksamhet och stödjande affärsverksamhet i hela Europa. Transaktionen förväntas slutföras under första kvartalet 2027, efter att erforderliga samrådsprocesser har genomförts och myndighetsgodkännanden har erhållits. Verksamheten är en ledande europeisk tillverkare av obestruket träfritt papper för kontorsbruk och kommersiellt tryck. Produktportföljen omfattar kontorspapper i arkformat, som säljs under egna varumärken såsom REY och Multicopy samt för stora OEM-kunder och kunder inom kontorsmaterial, och pappersrullar för kommersiella tryckerier och konverterare. Verksamheten har sitt huvudkontor i Belgien och två storskaliga, vertikalt integrerade
Midas Atlantic Partners, in Partnership With the Najafi Companies, Has Entered Into a Put Option Agreement With Sylvamo Relating to the Potential Acquisition of Its European Operations6.11.2026 12:04:00 CET | Press Release
Midas Atlantic Partners (“Midas Atlantic”), in partnership with The Najafi Companies, has signed a put option agreement with Sylvamo Corporation (“Sylvamo”) relating to the potential acquisition of its European operations (the “Business”). The transaction comprises Sylvamo’s uncoated freesheet paper mills in Saillat and Nymölla, as well as its forestry and supporting business operations across Europe. Closing is expected in the first quarter of 2027, once the required consultation processes are completed and regulatory approvals are obtained. The Business is a leading European producer of uncoated woodfree (UWF) paper for office and commercial printing. Its product portfolio spans cut-size office paper, sold under its own brands such as REY and Multicopy as well as on behalf of major OEM and office supplies customers, and paper reels for commercial printers and converters. Headquartered in Belgium, with two large-scale, vertically integrated pulp and paper mills, it serves a longstandi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom